recombinant hepatitis E vaccine (Changchun Institute of Biological Products)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant hepatitis E vaccine (Changchun Institute of Biological Products)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis E
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesChangchun Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChangchun Institute Of Biological Products Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis E

Other Information

ATC CodeN/A
Related LinksN/A